It does not look good to me. The numbers are not coming for anybody. This product is underperforming with lots of voice behind it. I was thinking Challenger and all the coaching was part of the problem. Spending too much time coaching and being coached vs actually selling, but DSI is not moving it either. One more year on Seroquel then the heads roll.
Movantik sees to be tanking
Aucun commentaire:
Enregistrer un commentaire